Unit
Tissue engineering applies principles of engineering and life sciences to create biological substitutes that restore, maintain, or improve tissue function. This section introduces the core concepts and interdisciplinary nature of the field.
- Definition and scope: Tissue engineering involves the use of scaffolds, cells, and bioactive molecules to construct functional tissue equivalents. It integrates cell biology, materials science, and mechanical engineering to address clinical needs such as skin grafts, cartilage repair, and organ replacements.
- Interdisciplinary foundations: The field draws from developmental biology to understand morphogenesis, from polymer chemistry to design biodegradable scaffolds, and from fluid dynamics to model nutrient transport in three-dimensional constructs.
- Clinical drivers: Shortages of donor organs affect hundreds of thousands of patients worldwide. Tissue engineering offers an alternative by building autologous grafts that reduce immune rejection and bypass waiting lists.
- Historical context: Early successes include engineered skin substitutes for burn victims, approved by regulatory agencies in the 1990s. These products demonstrated the feasibility of combining cultured cells with collagen matrices.
- Current challenges: Scaling up from thin tissues (e.g., skin) to thick, vascularized organs like liver or kidney remains a major hurdle. Ensuring uniform cell distribution and adequate nutrient supply in large constructs is an active research area.
- Ethical and regulatory considerations: Tissue-engineered products face unique regulatory pathways because they combine living cells with synthetic materials. Ethical issues include sourcing of stem cells and informed consent from donors.
- Economic impact: The global tissue engineering market is projected to exceed $30 billion by 2030, driven by aging populations and rising prevalence of degenerative diseases. Reimbursement models for advanced therapies are still evolving.
- Course overview: This course will guide learners through each step of constructing a tissue-engineered product, from selecting biomaterials and cells to fabricating scaffolds and testing in bioreactors. Emphasis is placed on reproducible methods and quality control.
Code Example
Pseudocode
protocol: expand primary chondrocytes
1. thaw cryovial in 37C water bath for 2 min
2. transfer cells to 15 mL tube containing 10 mL medium
3. centrifuge at 300 g for 5 min
4. aspirate supernatant and resuspend pellet in 1 mL fresh medium
5. count cells using trypan blue exclusion
6. seed at 5000 cells per cm2 in culture flask
7. incubate at 37C, 5% CO2, change medium every 3 days
8. passage at 80% confluence with trypsin-EDTAThis protocol illustrates standard cell culture steps used to obtain a sufficient number of cells for scaffold seeding. Strict aseptic technique and proper centrifugation speed are critical to maintain viability.
Quick Revision
- Tissue engineering combines scaffolds, cells, and signals to restore tissue function.
- Interdisciplinary collaboration is essential for successful construct design.
- Clinical need is driven by organ shortages and limitations of synthetic implants.
- Legacy products like engineered skin have paved the way for complex tissues.
- Key challenges include vascularization and regulatory compliance.